Esther Wohlfarth

8PUBLICATIONS
13CO-AUTHORS
Infectious agentsMedical bacteriologyMajor global burdens of diseaseGenomics and transcriptomicsBacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 10, 2026
Update on the comparative in vitro activity of cefiderocol and four β-lactam-β-lactamase-inhibitor combinations against clinically important Gram-negative pathogens.

|Dec 30, 2025
In Vitro Evaluation of Fosfomycin Combinations Against Metallo-β-Lactamase-Producing Klebsiella pneumoniae and Pseudomonas aeruginosa Clinical Isolates.

Esther Wohlfarth, Aurélien Dinh, Georgia Vrioni

|Dec 11, 2024
Antibiotic resistance and molecular characterization of non-invasive clinical Haemophilus influenzae isolates in Germany 2019 and 2020.

Thiemo Frank, Esther Wohlfarth, Heike Claus

|Jun 27, 2024
Antimicrobial Susceptibility of Bacterial Pathogens from Patients with Ocular Surface Infections in Germany, 2020-2021: A Comparison with the Data from Three Previous National Studies.

Esther Wohlfarth, Michael Kresken, Fabian Deuchert

|Jul 29, 2023
In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates.

Harald Seifert, Carina Müller, Danuta Stefanik

|May 27, 2023
In Vitro Activity of Cefiderocol against Clinical Gram-Negative Isolates Originating from Germany in 2016/17.

Esther Wohlfarth, Michael Kresken, Fabian Deuchert

Pageof 2

Frequent Collaborators

4 joint publications

Paul G Higgins

4 joint publications

Harald Seifert

4 joint publications

Michael Kresken

2 joint publications

Niels Pfennigwerth